Correction to: EJNMMI Research (2022) 12:56
Following publication of the original article [1], the following two errors in Table 2 came to the attention of the authors: the value '47' had been omitted from the row 'PS' ('Parkinsonian syndromes') and the title of the table contained the incorrect formatting '[18F]FE-PE2I' (that is, the number 18 had not been superscripted). The table has now been corrected in the published article, and the corrected table may be seen in this erratum.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Marner, L., Korsholm, K., Anderberg, L. et al. Correction: [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism. EJNMMI Res 13, 19 (2023). https://doi.org/10.1186/s13550-023-00970-x
Published:
DOI: https://doi.org/10.1186/s13550-023-00970-x